FDA Authorizes IQOS to be Marketed as Modified Risk Tobacco Product
The U.S. Food and Drug Administration (FDA) has given Altria Group the ok to market its heat not burn device, IQOS, as a modified...
FDA Advisory Panel Deals Blow to Phillip Morris International’s iQOS Device
Phillips Morris International, Inc. was dealt a slight blow on Thursday when a group of U.S. health advisers offered the opinion that the big...
Is the FDA on the Brink of True Harm Reduction?
In July, the FDA announced a new regulatory plan to focus on reducing nicotine levels in cigarettes, with the purpose of reducing cigarette addiction....
FDA Grants Modified Risk Authorization to 22nd Century Group’s VLN
22nd Century Group, Inc., a leading agricultural biotechnology company that is focused on tobacco harm reduction and reduced nicotine tobacco products, has announced that...
Philip Morris International to Regain Full U.S. Commercial Rights to IQOS
Altria has reached an agreement with Philip Morris International (PMI) relating to the IQOS Tobacco Heating System. Altria has revealed that it will receive...
British American Tobacco Releases 2018 Harm Reduction Focus Report
Harm reduction has been a major initiative and focus of British American Tobacco (BAT) in recent years and 2018 was no different. With the...
